1492 Capital Management LLC Editas Medicine, Inc. Transaction History

1492 Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$14.08 - $27.63 $635,233 - $1.25 Million	-45,116 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $1.2 Million - $1.83 Million	45,116 New	45,116 $1.2 Million
Q1 2021 May 12, 2021	SELL	$39.71 - $90.58 $116,469 - $265,671	-2,933 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $79,396 - $247,398	2,933 New	2,933 $206,000

244

58.9M

494K

417K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $208M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of 1492 Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on 1492 Capital Management LLC with notifications on news.